adults are currently using a GLP-1 agonist, while roughly 1 in 8 reports having used one at some point
This understanding informs dosing decisions and helps you adjust protocols based on your specific goals
Additionally, MT activated enzymatic (superoxide dismutase [SOD], glutathione peroxidase [GPX], catalase [CAT], glutathione reductase [GR], ascorbate peroxidase [APX], peroxidase [POD]) and non-enzymatic (ascorbic acid [AsA], glutathione [GSH]) antioxidant systems, and elevated AsA/DHA and GSH/GSSG ratios, maintaining redox homeostasis
marketed for diabetes as Mounjaro and for weight management under trade names such as Zepbound) Tirzepatide combines GLP-1 and GIP receptor agonism and has shown the largest average weight losses of any medication to date
PloS One (2015) 10:e0130188